Cardiomyopathy Trial, Recruiting (NCT06243653)

Cardiomyopathy Trial, Recruiting NCT06243653 Sponsor: Samsung Medical Center Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06243653 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are at least 19 years old.
You have symptoms of heart failure (such as shortness of breath during activity or at rest) and your heart's pumping function is reduced (confirmed by a heart scan or test).
You already need a procedure called a coronary angiography (an imaging test to look at the blood vessels of your heart) for medical reasons.
You are willing and able to sign a consent form to participate.

Who may not be able to join:

Your coronary angiography shows significant blockages in your heart's blood vessels (confirm with trial site for exact measurements).
You are already scheduled to receive a heart transplant or have a heart pump device implanted.
Your heart failure is caused by certain specific heart conditions, including a stiff/restrictive heart muscle disease, active inflammation of the heart, or scarring around the heart.
You have a significant heart valve problem that requires surgery.
You have a serious non-heart-related illness where life expectancy is less than one year.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ki Hong Choi, MD, Samsung Medical Center

Phone: 82-2-3410-3419

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06243653

Sponsor: Samsung Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 82-2-3410-3419

More information: https://clinicaltrials.gov/study/NCT06243653

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are at least 19 years old.
You have symptoms of heart failure (such as shortness of breath during activity or at rest) and your heart's pumping function is reduced (confirmed by a heart scan or test).
You already need a procedure called a coronary angiography (an imaging test to look at the blood vessels of your heart) for medical reasons.
You are willing and able to sign a consent form to participate.

Who may not be able to join:

Your coronary angiography shows significant blockages in your heart's blood vessels (confirm with trial site for exact measurements).
You are already scheduled to receive a heart transplant or have a heart pump device implanted.
Your heart failure is caused by certain specific heart conditions, including a stiff/restrictive heart muscle disease, active inflammation of the heart, or scarring around the heart.
You have a significant heart valve problem that requires surgery.
You have a serious non-heart-related illness where life expectancy is less than one year.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Samsung Medical Center

Registry

ClinicalTrials.gov

Start date

9 August 2023

Est. completion

31 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Proportion of HFiEF* at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov